期刊文献+

2型糖尿病糖耐量正常一级亲属心血管危险因素的干预研究

Relatives of Type 2 Diabetes Glucose Tolerance Normal Level of Cardiovascular Risk Factors in Intervention Studies
下载PDF
导出
摘要 目的探讨糖耐量正常的2型糖尿病(T2DM)患者一级亲属(FDRs)群体心血管危险因素干预策略,为其心血管病(CVD)的早期预防提供参考依据。方法将60例糖耐量正常T2DM的FDRs随机分为干预组40例,对照组20例。两组均给予糖尿病、心血管疾病健康知识讲座,合理运动指导,定期门诊及电话随访,危险因素监测,信息化动态管理等,干预组在上述基础上予以相对固定的营养餐,进行个体化干预。比较干预前后两组的体质量指数(BMI)、腰臀比、血压、空腹血糖、血胰岛素水平、胰岛素抵抗指数(HOMA-IR)、血脂、尿微量白蛋白、C反应蛋白等指标,根据"缺血性心血管病(ICVD)10年发病危险评估量表",对所有研究对象干预前后进行ICVD危险评分,评估CVD发病风险。结果干预后6、12、24个月,相比对照组,干预组多重危险因素明显回归,心血管绝对风险度明显降低。结论 T2DM糖耐量正常FDRs存在CVD的多重危险因素,合理的营养综合干预可使CVD获益最大化;对心血管高危群体应选择个体化预防方案,加强长期的一级预防。 Objective Discuss cardiovascular risk factors intervention methods for FDRs of T2DM patients with normal glucose tolerance, and provide early references for the prophylaxis of T2DM CVD. Methods 60 cases of first-degree relatives of type 2 diabtes mellitus with normal glucose tolerance were randomly allocated to two groups:nutrition therapy intervention(40 cases), the control group(20 cases). Both groups were given to health lectures of diabetes and cardiovascular disease. To reasonable exercise guidance, periodic outpatient and telephone follow-up, risk factor surveillance, information analysis;the nutritious meals are provided for dynamic intervention group based on the above, and individualized intervention. Body mass index(BMI), waist hip rate, blood pressure, fasting blood glucose(FBG), fasting insulin and HOMA-IR, blood fat, urinary albumin and CRP were measured before and after intervention, and compared. According to”ischemic cardiovascular disease(ICVD) 10 year incidence risk assessment table”,calculate ICVD risk score for all subjects before and after intervention. And assess risk of its 10-year ICVD. Results After intervention, compared with the control group, multiple risk factors significantly improved of the intervention group at 6 months, 12 months, 24 months. Cardiovascular absolute risk level significantly lower. Conclusion T2DM with normal glucose tolerance FDRs exist multiple risk factors for CVD. Right nutrition comprehensive intervention can benefit maximization CVD. Long-term primary prevention for cardiovascular risk groups should be strengthen, and individualized prevention program should be selected.
机构地区 枣庄市立医院
出处 《中国医药指南》 2014年第6期25-27,共3页 Guide of China Medicine
关键词 2型糖尿病 一级亲属 心血管疾病 风险评估 营养干预 Type 2 diabetes First degree relatives Cardiovascular diseases Risk assessment Nutrition intervention
  • 相关文献

参考文献12

  • 1邹映珍,肖春玲,曾兰英,黄世红,董彦敏.药膳联合生活方式干预对糖调节受损患者的影响[J].中华现代护理杂志,2010,16(15):1778-1780. 被引量:5
  • 2张磊,王岩,齐秀英.2型糖尿病合并冠心病的危险因素的配对病例对照研究[J].中国糖尿病杂志,2007,15(8):501-502. 被引量:9
  • 3张立松,唐根富,张春林,程威,陈霞,张燕.饮食和运动干预对2型糖尿病患者血糖的影响研究[J].中华疾病控制杂志,2008,12(5):493-494. 被引量:17
  • 4Matthews DR,Hosker JP, Rudenski AS,et al.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologi a,1985,28(7):412-419.
  • 5中华医学会肝脏病学分会脂肪肝和酒精性脂肪肝病学组.非酒精性脂肪肝肝病诊疗指南.中华肝脏病组织,2006,:161-163.
  • 6国家'十五'攻关'冠心病、脑卒中综合危险度评估及干预方案的研究'课题组.国人缺血性心血管病发病危险的评估方法及简易评估工具的开发研究[J].中华心血管病杂志,2003,31(12):893-901. 被引量:302
  • 7Utzschneider KM,van de Lagemaat A,Faulenbach MV, et al.lnsulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes[./].Obesity(silver spring),2010,18( 9):1781-178 7.
  • 8Kusminski CM,Scherer PE.The road from discovery to clinic: adiponectin as a biomarker of metabolic status[J].Clin Pharmacol Ther,2009,86(6):592-595.
  • 9Chen BH,Song Y, Ding EL,et al.Circulating levels of resist in and risk of type 2 diabetes in men and women: results from two prospective cohorts[J].Diabetes Care,2009,32(2): 329-334.
  • 10Goldstein BJ.Insulin resistance as the core defect in type 2 diabetes mullites[J].Am J Cardio12002,90(5A):3G-10G.

二级参考文献38

  • 1李玲,厉平,王贵新,姜甲军,刘秀明,尚小静.糖耐量受损者胰岛素敏感性及胰岛β细胞功能的研究[J].中华糖尿病杂志(1006-6187),2005,13(2):87-89. 被引量:15
  • 2霍丽梅,宋光耀,马博清,叶蔚,陈树春,马慧娟.2型糖尿病患者非肥胖一级亲属血清脂联素与β细胞功能和胰岛素抵抗相关性研究[J].中华内分泌代谢杂志,2006,22(1):23-24. 被引量:7
  • 3邓志明,周智广,杨琳,谭少珍,何凌,陈小燕,亓海英,王建平.LADA和2型糖尿病一级亲属胰岛β细胞功能的变化[J].中国糖尿病杂志,2006,14(2):84-87. 被引量:3
  • 4World Health Organization. Definition, diagnosis and olassification of diabetes mellitus and its cimplication. Partl: Diagnesis and classifications of diabetes meUitus. In : Geneva: WHO Department of Non-communicable Diseases Survillance, 1999.
  • 5AmericanDiabetes Association, Alexandria, Virginia, USA. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care,2003,26 ( Suppl1 ) : S5 -20.
  • 6宋立民,洪恂,丁绪亮,等.现代中药学大辞典(上册).北京:人民卫生出版社,2001:33-954,2412-2415.
  • 7McGarry JD.Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.Diabetes,2001,50(suppl 2):6-7.
  • 8Taskinen MR.Diabetic dyslipidaemia:from basic research to clinical practice.Diabetologia,2003,46:733-743.
  • 9Zammit VA,Waterman IJ,Topping D,et al.Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance.J Nutr,2001,131:2074-2077.
  • 10Adiels M,Olofsson SO,Taskinen MR,et al.Diabetic dyslipidaemia.Curr Opin Lipidol,2006,17:238-246.

共引文献373

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部